<DOC>
	<DOCNO>NCT02518061</DOCNO>
	<brief_summary>This retrospective study involve revision clinical , instrumental pathologic data estimate cohort maximum 145 patient glioma treat surgery radical intent center .</brief_summary>
	<brief_title>11C-Methionine PET Prognostic Marker Gliomas</brief_title>
	<detailed_description>This retrospective observation involve revision clinical , instrumental pathologic data estimate cohort 145 patient glioma treat surgery radical intent center . We review 11C-Methionine PET data acquire within 30 day prior surgery analyze principal image characteristic respect IDH1 mutation status , MGMT promoter methylation 1p/19q co-deletion . These marker study tumor tissue obtain surgery , use diagnostic purpose store paraffin .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Diagnosis glioma 11CMethionine within 30 day surgery Absence tumor specimen No clinical data 11CMethionine evaluate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Glioma ; 11C-Methionine PET</keyword>
</DOC>